Chronic Inflammatory Demyelinating Polyneuropathy Drug Report

By www.reliablebusinessinsights.com

Report Details

Report Name

Global And United States Chronic Inflammatory Demyelinating Polyneuropathy Drug Market Report & Forecast 2024-2031 Story

Pages

99

Price

$ 4350

Features

Chronic Inflammatory Demyelinating Polyneuropathy Drug Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              CSL Ltd
GeNeuro SA
MedDay SA
Octapharma AG
Pfizer Inc
Takeda
Teijin Pharma Ltd